Skip to Content

News Series Conferences Insights FeaturesMORE

FORTUNE LIVE MEDIA

FORTUNE EDUCATION

SIGN IN

Loading Video...

Mylan’s Biggest EpiPen Competitor Is Back

October 26, 2016 17:00 PM UTC
- Updated August 17, 2018 16:10 PM UTC

Kaleo will return to market in the first half of 2017

Sections

Tags

allergiesmoneynewspharmapricingzazoom

Rankings

100 Best Companies
Fortune 500
Global 500
Fortune 500 Europe
Most Powerful Women
Future 50
World’s Most Admired Companies
See All Rankings

Sections

Finance
Leadership
Success
Tech
Asia
Europe
Fortune Crypto
Health
Retail
Lifestyle
Politics
Newsletters
Magazine
Features
Commentary
MPW
CEO Initiative
Conferences
Personal Finance
Education

Customer Support

Frequently Asked Questions
Customer Service Portal
Privacy Policy
Terms of Use
Single Issues for Purchase
International Print

Commercial Services

Advertising
Fortune Brand Studio
Fortune Analytics
Fortune Conferences
Business Development

About Us

About Us
Terms and Conditions
Editorial Calendar
Press Center
Work at Fortune
Diversity and Inclusion
Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.